tradingkey.logo

Evoke Pharma Inc

EVOK
11.000USD
0.000
Close 12/19, 16:00ETQuotes delayed by 15 min
18.95MMarket Cap
LossP/E TTM

Evoke Pharma Inc Earnings Date

Period
FY2024 Earnings Date
Revenue(YoY)
10.25M
97.84%
EPS(YoY)
-2.81
89.96%
Analyst Rating
HOLD
2025-12-09

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What is the total revenue of Evoke Pharma Inc?

According to Evoke Pharma Inc's FY2024 earnings report, its total revenue reached 10.25M, with a year-on-year change of 97.84%.

What is the Earnings Per Share (EPS) of Evoke Pharma Inc?

According to Evoke Pharma Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -2.809, with a year-on-year change of 89.96%.

What is the net income of Evoke Pharma Inc?

According to Evoke Pharma Inc's FY2024 earnings report, its net income was -5.35M, with a year-on-year change of 31.31%.

What is the net margin of Evoke Pharma Inc?

According to Evoke Pharma Inc's FY2024 earnings report, its net profit margin was -52.22%, with a year-on-year change of 65.28%.

What is the gross margin of Evoke Pharma Inc?

According to Evoke Pharma Inc's FY2024 earnings report, its gross margin was 96.52%, with a year-on-year change of 0.44%.

What is the debt-to-asset ratio of Evoke Pharma Inc?

According to Evoke Pharma Inc's FY2024 earnings report, its debt-to-asset ratio was 28.54%, with a year-on-year change of -59.65%.

What is the Return on Equity (ROE) of Evoke Pharma Inc?

According to Evoke Pharma Inc's FY2024 earnings report, its Return on Equity (ROE) was -240.09%, with a year-on-year change of 76.81%.

What is the Return on Assets (ROA) of Evoke Pharma Inc?

According to Evoke Pharma Inc's FY2024 earnings report, its Return on Assets (ROA) was -43.54%, with a year-on-year change of 47.15%.

What is the operating profit of Evoke Pharma Inc?

According to Evoke Pharma Inc's FY2024 earnings report, its operating profit was -5.20M, with a year-on-year change of 29.97%.

What are the current assets of Evoke Pharma Inc?

According to Evoke Pharma Inc's FY2024 earnings report, its current assets were 17.24M, with a year-on-year change of 152.50%.

What are the total assets of Evoke Pharma Inc?

According to Evoke Pharma Inc's FY2024 earnings report, its total assets of Evoke Pharma Inc were 17.52M, with a year-on-year change of 147.84%.

What are the total liabilities of Evoke Pharma Inc?

According to Evoke Pharma Inc's FY2024 earnings report, its total liabilities of Evoke Pharma Inc were 10.48M, with a year-on-year change of 8.63%.

What is the total equity of Evoke Pharma Inc?

According to Evoke Pharma Inc's FY2024 earnings report, its total equity of Evoke Pharma Inc was 7.04M, with a year-on-year change of 372.84%.

What is the net operating income of Evoke Pharma Inc?

According to Evoke Pharma Inc's FY2024 earnings report, its net operating income of Evoke Pharma Inc was -5.35M, with a year-on-year change of 31.31%.

What is the net investment of Evoke Pharma Inc?

According to Evoke Pharma Inc's FY2024 earnings report, its net investment of Evoke Pharma Inc was --, with a year-on-year change of --.

What is the net financing of Evoke Pharma Inc?

According to Evoke Pharma Inc's FY2024 earnings report, its net financing of Evoke Pharma Inc was 14.32M, with a year-on-year change of 12100.33%.
KeyAI